|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02348 DAWNRAYS PHARMA
Nominal 
1.200 0.000 (0.000%) | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 220,200 | 338,400 | 434,266 | 393,139 |
| Net Cash from / (used in) Investing Activities | -- | 205,170 | (387,573) | (175,013) | (284,202) |
| Net Cash from / (used in) Financing Activities | -- | (189,438) | 2,070 | (92,701) | (129,754) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 235,932 | (47,103) | 166,552 | (20,817) |
| Cash & Cash Equivalents at beginning of period | -- | 366,826 | 411,682 | 237,744 | 258,486 |
| Effect of Foreign Exchange Rate Changes | -- | 12,917 | 2,247 | 7,386 | 75 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 615,675 | 366,826 | 411,682 | 237,744 |
| Remarks: | Real time quote last updated: 31/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 104,572 |
| %Change | -78.791% |
| EPS / (LPS) | RMB 0.070 |
| NBV Per Share (¥) | RMB 2.198 |